Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityXian-Yang Li, Mark J. Smyth, Jason Madore et al.|Cancer Discovery|2019Cited by 269
Control of Metastases via Myeloid CD39 and NK Cell Effector FunctionJuming Yan, Mark J. Smyth, Xian-Yang Li et al.|Cancer Immunology Research|2020Cited by 81
CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, John Stagg, Isabelle Cousineau et al.|Cancer Immunology Research|2022Cited by 74